Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“We’re approaching the most important transition in MAPS’ over 33-year MDMA-assisted psychotherapy drug development effort, beginning with MAPS’ founding in April 1986. This transition is anticipated to take place in April 2020, and will be catalyzed by the interim analysis of MAPS’ first of two Phase 3 studies of MDMA-assisted psychotherapy for people with severe, chronic, posttraumatic stress disorder (PTSD).”
· From the Desk of Rick Doblin, Ph.D. – Winter 2019 (MAPS Bulletin Vol. 29, No. 3) · own post

Interim analysis by the Data Monitoring Committee on the first 60 of 100 subjects, for sample size re-estimation.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.